Commission Milestones

Commission Milestones

DEC 10 2020

Initial working groups kickoff -75 KOLS participating​

JUL 7-9 2021

Moving Mountains SHARED Family Conference in Westminster, CO
-Dup15q, 8p, and Ring14 families and professionals represented.

Start of data collection into the Clinical Research Platform (powered by RARE-X)​​

DEC 2020 - MAR 2021

10+ bi-weekly WG meetings

  • Community Engagement
  • Animal Models
  • In Vitro Models
  • Genomics/Bioinformatics

JUL 06 2021

Moving Mountains Science Conference in
Westminster, CO
– 45 researchers (22 in-person and 23 virtual)

Writing session for the Roadmap
Interact with the families ​

Mar 03 2021

Virtual  Collective Impact Conference
 – Reporting out of working groups​

JAN 2022

Illumina Partnership Finalized​

FUTURE

We continue to collect data and biosamples and are preparing to write several grants and an another
paper.​

JAN 2022

Launched the Neurogenetic Multidisciplinary Clinic at Children’s Hospital of Colorado. 

Clinical Data entered in Clinical Research Data Platform.​

AUG 2022

Published paper in AJHG​

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.
  • Lead with knowledge from patients. Currently, there is no cure for 8p disorders, nor is there a standard course of treatment.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Raise transformative funding for pioneering scientific research into treatments for a complex, rare disease involving 250+ affected genes on the short arm of the 8 th chromosome (8p). Rearrangements of these genes causes significant abnormalities to the entire neurological system, thus all organs and functions of the body– with variance in cognitive functions, gross motor skills, social development and other challenges during infancy, and throughout life;
  • Empower a unified community of 8p patients and their families so they can have meaningful lives today; and
  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.